1. Home
  2. PVLA vs ODC Comparison

PVLA vs ODC Comparison

Compare PVLA & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • ODC
  • Stock Information
  • Founded
  • PVLA 2015
  • ODC 1941
  • Country
  • PVLA United States
  • ODC United States
  • Employees
  • PVLA N/A
  • ODC N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • PVLA Health Care
  • ODC Consumer Discretionary
  • Exchange
  • PVLA Nasdaq
  • ODC Nasdaq
  • Market Cap
  • PVLA 280.4M
  • ODC 316.2M
  • IPO Year
  • PVLA N/A
  • ODC N/A
  • Fundamental
  • Price
  • PVLA $22.77
  • ODC $45.81
  • Analyst Decision
  • PVLA Strong Buy
  • ODC
  • Analyst Count
  • PVLA 7
  • ODC 0
  • Target Price
  • PVLA $44.43
  • ODC N/A
  • AVG Volume (30 Days)
  • PVLA 82.1K
  • ODC 28.3K
  • Earning Date
  • PVLA 05-15-2025
  • ODC 06-05-2025
  • Dividend Yield
  • PVLA N/A
  • ODC 1.35%
  • EPS Growth
  • PVLA N/A
  • ODC 18.90
  • EPS
  • PVLA N/A
  • ODC 3.13
  • Revenue
  • PVLA N/A
  • ODC $465,340,000.00
  • Revenue This Year
  • PVLA N/A
  • ODC N/A
  • Revenue Next Year
  • PVLA N/A
  • ODC N/A
  • P/E Ratio
  • PVLA N/A
  • ODC $14.53
  • Revenue Growth
  • PVLA N/A
  • ODC 8.24
  • 52 Week Low
  • PVLA $6.20
  • ODC $29.48
  • 52 Week High
  • PVLA $29.27
  • ODC $49.72
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • ODC 64.51
  • Support Level
  • PVLA N/A
  • ODC $41.50
  • Resistance Level
  • PVLA N/A
  • ODC $44.26
  • Average True Range (ATR)
  • PVLA 0.00
  • ODC 1.00
  • MACD
  • PVLA 0.00
  • ODC 0.50
  • Stochastic Oscillator
  • PVLA 0.00
  • ODC 97.80

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: